Form 4 for TLSI TriSalus Life Sciences, Inc.

Accepted 2026-05-15 16:39:01 ET · period of report 2026-05-14 · accession 0001628280-26-035662 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2026-05-15 16:39	2026-05-14	TLSI	Stansky Michael P	Dir	A - Grant	$0.00	+43.6K	830.7K	+6%	$0
D	2026-05-15 16:39	2026-05-14	TLSI	Stansky Michael P	Dir	A - Grant	$0.00	+47.0K	139.5K	+51%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-05-14	A	A	23,501	$0.00	810,633	D	—	—	(F1) Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
2	Common	Common Stock	2026-05-14	A	A	20,089	$0.00	830,722	D	—	—	(F2) Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer.
3	Derivative	Director Stock Option (right to buy)	2026-05-14	A	A	47,003	$0.00	139,540	D	$2.52 · — to 2036-05-13	47,003 Common Stock	(F4) The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.